Omeros Corp. (OMER)
13.21
-0.80
(-5.71%)
USD |
NASDAQ |
Nov 20, 16:00
13.22
0.00 (0.00%)
After-Hours: 20:00
Omeros Enterprise Value : 1.180B for Nov. 20, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 20, 2026 | 1.180B |
| November 19, 2026 | 1.240B |
| November 18, 2026 | 1.280B |
| November 17, 2026 | 1.233B |
| November 16, 2026 | 1.438B |
| November 13, 2026 | 1.498B |
| November 12, 2026 | 1.535B |
| November 11, 2026 | 1.547B |
| November 10, 2026 | 1.484B |
| November 09, 2026 | 1.502B |
| November 06, 2026 | 1.456B |
| November 05, 2026 | 1.467B |
| November 04, 2026 | 1.549B |
| November 03, 2026 | 1.556B |
| November 02, 2026 | 1.523B |
| October 30, 2026 | 1.568B |
| October 29, 2026 | 1.606B |
| October 28, 2026 | 1.527B |
| October 27, 2026 | 1.498B |
| October 26, 2026 | 1.409B |
| October 23, 2026 | 1.430B |
| October 22, 2026 | 1.451B |
| October 21, 2026 | 1.407B |
| October 20, 2026 | 1.428B |
| October 19, 2026 | 1.413B |
| Date | Value |
|---|---|
| October 16, 2026 | 1.402B |
| October 15, 2026 | 1.594B |
| October 14, 2026 | 1.568B |
| October 13, 2026 | 1.601B |
| October 12, 2026 | 1.657B |
| October 09, 2026 | 1.672B |
| October 08, 2026 | 1.619B |
| October 07, 2026 | 1.591B |
| October 06, 2026 | 1.574B |
| October 05, 2026 | 1.603B |
| October 02, 2026 | 1.581B |
| October 01, 2026 | 1.571B |
| September 30, 2026 | 1.613B |
| September 29, 2026 | 1.553B |
| September 28, 2026 | 1.566B |
| September 25, 2026 | 1.612B |
| September 24, 2026 | 1.616B |
| September 23, 2026 | 1.660B |
| September 22, 2026 | 1.682B |
| September 21, 2026 | 1.498B |
| September 18, 2026 | 1.453B |
| September 17, 2026 | 1.495B |
| September 16, 2026 | 1.415B |
| September 15, 2026 | 1.403B |
| September 14, 2026 | 1.424B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Eli Lilly & Co. | 1.313T |
| Aytu BioPharma, Inc. | 20.95M |
| Daré Bioscience, Inc. | 3.283M |
| Jaguar Health, Inc. | -3.223M |
| Structure Therapeutics, Inc. | -82.04M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -63.82M |
| Revenue (Quarterly) | 35.93M |
| Total Expenses (Quarterly) | 99.76M |
| EPS Diluted (Quarterly) | -0.7859 |
| Gross Profit Margin (Quarterly) | 97.26% |
| Profit Margin (Quarterly) | -177.6% |
| Earnings Yield | 8.47% |
| Normalized Earnings Yield | 14.28 |